IHS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

IH

Mkt Cap

$2.85B

Volume

266.31K

Next Earnings

November 11th

Loading chart

IH

IHSIHS Holding Limited

IHS

Pay with—

Available Balance0.00

IH

Mkt Cap

$2.86B

Volume

266.31K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Why This Fund Made a $35 Million Bet on IHS Towers During a Major ShakeupPSquared Asset Management acquired 4.3 million shares of IHS Holding Limited for approximately $35 million in Q1 2026, representing a high-conviction bet on the telecommunications infrastructure provider. The investment reflects confidence in IHS's improved financial durability following currency volatility challenges, with the company posting solid Q1 results including 6% revenue growth and reduced leverage ratios. IHS is undergoing strategic transactions including a proposed $6.2 billion sale to MTN Group.The Motley Fool · May 14, 2026

IHS Towers To Go Private In $6.2 Billion MTN BuyoutIHS Holding Limited has agreed to be acquired by MTN Group Limited in an all-cash transaction valued at $6.2 billion, with shareholders receiving $8.50 per share. The deal, unanimously approved by IHS Towers' board, represents a 239% premium over the March 2024 strategic review announcement price and is expected to close in 2026 pending regulatory approvals. Upon completion, IHS Towers will become a wholly owned subsidiary of MTN and be delisted from public markets.Benzinga · Feb 17, 2026

Caesars Stock Down 30% This Past Year but One Fund Is Wagering $29 Million on a TurnaroundQuaker Capital Investments increased its stake in Caesars Entertainment by 279,390 shares to 1.08 million shares worth $29.28 million in Q3, betting on a turnaround despite the stock falling 30% over the past year. While Caesars faces earnings pressure with flat Q3 revenue and declining profitability, the company is reducing leverage and possesses valuable real estate assets and a growing digital footprint.The Motley Fool · Jan 1, 2026

US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'U.S. stock futures were flat on Tuesday as investors remained cautious ahead of the FOMC meeting. Analysts say the only certainty is that 'things will remain uncertain for the time being'.Benzinga · Mar 18, 2025

The Latest Analyst Ratings For IHS HoldingAnalysts' ratings for IHS Holding (NYSE:IHS) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 2 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.62, a high estimate of $15.00, and a low estimate of $6.00. A 21.33% drop is evident in the current average compared to the previous average price target of $13.50. Analyzing Analyst Ratings: A Detailed Breakdown In examining recent analyst actions, we gain insights into how financial experts perceive IHS Holding. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Colby Synesael TD Cowen Lowers Buy $13.00 $15.00 Maurice Patrick Barclays Lowers Overweight $6.00 $8.00 Gregory Williams TD Cowen Lowers Outperform $15.00 $19.00 Eric Luebchow Wells Fargo Lowers Overweight $8.50 $12.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to IHS Holding. This offers insight into analysts' perspectives on ...Full story available on Benzinga.comBenzinga · May 15, 2024

Zacks Industry Outlook Highlights IHS Holding and DZSIHS Holding and DZS have been highlighted in this Industry Outlook article.Zacks Investment Research · Apr 30, 2024

2 Communication Stocks Likely to Stand Firm Amid Industry GloomThe infrastructure upgrade for digital transformation, fiber densification and 5G rollout should help the Zacks Communication - Infrastructure industry thrive despite near-term headwinds. IHS and DZSI are likely to benefit from the continued transition to cloud networks.Zacks Investment Research · Apr 29, 2024

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...Benzinga · Mar 26, 2024

Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On TuesdayU.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday. Shares of Tesla Inc (NASDAQ: TSLA) rose sharply during Tuesday’s session amid reports suggest Italy has approached the company about electric truck production. Multiple reports are highlighting new reporting from Italian news outlet Il Sole 24 Ore, suggesting Italy’s Industry Ministry officials have reached out to Tesla in regards to potentially manufacturing electric trucks in the country. Tesla shares surged 5.8% to $182.65 on Tuesday. Here are some other big stocks recording losses in today’s session. Praxis Precision Medicines Inc (NASDAQ: PRAX) shares jumped 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) surged 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Krispy Kreme, Inc. ...Benzinga · Mar 26, 2024

IHS Holding (IHS) Beats Q4 Earnings and Revenue EstimatesIHS Holding (IHS) delivered earnings and revenue surprises of 428.57% and 6.33%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Mar 12, 2024

to start trading

IH

IHSIHS Holding Limited

IHS

Pay with—

Available Balance0.00

Your PositionYou don't own any IHS yet.

Related Tickers

Earnings